Sun Pharma Advanced Research Company Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
SPARC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
SPARC has informed the exchanges that its trading window will remain closed from Tuesday, July 1, 2025 until 48 hours after the declaration of its unaudited financial results for the quarter ended June 30, 2025 (Q1 FY26). This is a standard compliance measure under SEBI's Insider Trading Regulations and the company's own code of conduct to prevent insiders from trading during the silent period before results. The date of the board meeting to approve the Q1 FY26 results has not yet been announced and will be communicated later. The intimation was signed by Kajal Damania, Company Secretary and Compliance Officer.
This is a routine regulatory filing with no direct impact on the stock price. However, it signals that Q1 FY26 earnings are approaching, and investors can expect a board meeting announcement and results declaration in the coming weeks. During the closed window, designated insiders are barred from trading in SPARC shares.